Dacron补片在颈动脉内膜切除术中的长期有效性与安全性
该回顾性研究纳入200例符合NASCET标准的症状性或无症状颈动脉狭窄患者,评估Dacron补片行颈动脉内膜切除术的长期安全性及有效性。5年总生存率93.7%、无卒中生存率97.6%、无再狭窄生存率97.5%。女性再狭窄风险显著高于男性,出血事件与夹闭时间延长相关。
要点
- Dacron补片在颈动脉内膜切除术中提供持久的长期卒中保护和通畅性。
- 女性5年无再狭窄生存率显著低于男性(88.4% vs 98.0%,P=0.017)。
- 出血事件与显著延长的夹闭时间相关,夹闭时间或可作为术后出血风险的早期指标。
核心结论
- Dacron补片颈动脉内膜切除术提供持久的长期卒中保护和通畅性,围术期及晚期并发症率处于报告范围的低端。
- 女性再狭窄风险可能增加,需在随访中加强警惕和更密切的双功超声监测。
- 结果支持继续使用Dacron补片作为颈动脉重建的安全有效选择。
研究设计与样本
- 回顾性分析纳入200例符合NASCET标准的症状性颈动脉狭窄(任意程度)或无症状狭窄(NASCET分级≥70%)患者。
- 所有患者接受标准化Dacron补片关闭的颈动脉内膜切除术。
- 通过结构化临床随访和系列双功超声评估5年围术期数据、生存率、无卒中生存率和无再狭窄(≥70%再狭窄)生存率。
- 采用Kaplan-Meier估计和亚组分析(按症状状态、基线狭窄严重程度和性别),使用Log-Rank和/或Wilcoxon检验分析亚组差异。
主要发现
- 200例患者中观察到26例不良事件(12.9%),出血事件仅与显著延长的夹闭时间相关(P=0.0221和两次P<0.0001)。
- 大多数并发症(8.0%)发生在随访期间,无死亡与卒中或再狭窄相关。
- 5年总生存率93.7%,无卒中生存率97.6%,无再狭窄生存率97.5%。
- 症状性患者生存率(91.8% vs 95.7%)和无卒中生存率(96.2% vs 99.0%)略低于无症状患者。
- 不同NASCET狭窄亚组间结局无显著差异;女性5年无再狭窄生存率(88.4%)低于男性(98.0%;P=0.017),卒中率在两性间保持低水平且相似。
关键数值与推荐
- 症状性狭窄定义为术前6个月内同侧短暂性脑缺血发作或卒中。
- 无症状狭窄纳入标准为NASCET分级≥70%。
- 再狭窄评估标准为≥70%再狭窄。
- 出血事件与显著延长的夹闭时间相关(P=0.0221和两次P<0.0001)。
- 女性5年无再狭窄生存率88.4% vs 男性98.0%(P=0.017)。
临床怎么用
- Dacron补片可用于颈动脉内膜切除术的颈动脉重建,长期卒中保护和通畅性良好。
- 术中夹闭时间延长可能提示术后出血风险增加,可作为早期预警指标。
- 女性患者术后应加强双功超声随访监测再狭窄。
- 症状性患者基线血管风险较高,术后生存率略低,需更密切管理。
局限性
- 回顾性研究设计可能引入选择偏倚和信息偏倚。
- 样本量200例,亚组分析(如性别、症状状态)统计效能有限。
- 单中心经验,结果外推需谨慎。
- 未与其他补片材料或直接缝合进行随机对照比较。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Carotid endarterectomy (CEA) remains the gold-standard treatment for high-grade carotid artery stenosis. While patch angioplasty reduces perioperative complications and restenosis risk compared to primary closure, the optimal patch material remains debated. This study evaluates the long-term safety and effectiveness of CEA with Dacron patch closure regarding overall survival, stroke prevention, and restenosis rates. METHODS: A retrospective analysis was performed on 200 patients who met the inclusion criteria of either symptomatic carotid stenosis of any degree according to the North American Symptomatic Carotid Endarterectomy Trial (NASCET) criteria, or asymptomatic stenosis with a NASCET grade ≥70%. All patients underwent CEA with standardized Dacron patch closure. Symptomatic stenosis was defined as ipsilateral transient ischemic attack or stroke within 6 months preoperatively. Perioperative data, survival, stroke-free survival, and freedom from restenosis (≥70% restenosis) were assessed through structured clinical follow-up and serial duplex ultrasound over 5 years. Kaplan-Meier estimates and subgroup analyses were performed according to symptomatic status, baseline stenosis severity, and sex. Log-Rank and/or Wilcoxon Tests were applied to analyze differences between the subgroups. RESULTS: Among 200 patients, 26 adverse events (12.9%) were observed, with bleeding events exclusively associated with significantly prolonged clamping times (P = 0.0221 and twice P < 0.0001). Most complications (8.0%) occurred during follow-up, and no deaths were linked to stroke or restenosis. At 5 years, overall survival was 93.7%, freedom from stroke was 97.6%, and freedom from restenosis was 97.5%. Symptomatic patients showed slightly lower survival (91.8% vs. 95.7%) and stroke-free survival (96.2% vs. 99.0%) compared to asymptomatic patients, reflecting higher baseline vascular risk. No significant differences in outcome were observed across different NASCET stenosis subgroups. However, a significant sex difference was found in restenosis rates: 5-year freedom from restenosis was lower in women (88.4%) than in men (98.0%; P = 0.017). Stroke rates remained low and similar between sexes. CONCLUSION: CEA with Dacron patch closure provides durable long-term stroke protection and patency, with perioperative and late complication rates at the lower end of reported ranges. All bleeding events linked to significantly prolonged clamping times, suggesting intraoperative clamping duration may serve as an early indicator for postoperative bleeding risk. Our data advocate for a potentially increased risk of restenosis in females, which may warrant heightened vigilance and closer duplex ultrasound surveillance during follow-up. These results of this study support the continued use of Dacron patches as a safe and effective option for carotid reconstruction.
引用
- Garabet W, Mulorz J, Mazrekaj A, et al. Long-Term Effectiveness and Safety of Dacron Patch (Uni-GraftⓇ) Closure in Carotid Endarterectomy. Ann Vasc Surg. 2025. PMID: 41067522. doi:10.1016/j.avsg.2025.09.040
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。